119 related articles for article (PubMed ID: 20046078)
1. Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker.
Yoo EH; Kim HJ; Lee ST; Kim WS; Kim SH
Korean J Lab Med; 2009 Dec; 29(6):491-6. PubMed ID: 20046078
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
3. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.
Suzuki R; Suzumiya J; Nakamura S; Aoki S; Notoya A; Ozaki S; Gondo H; Hino N; Mori H; Sugimori H; Kawa K; Oshimi K;
Leukemia; 2004 Apr; 18(4):763-70. PubMed ID: 14961041
[TBL] [Abstract][Full Text] [Related]
4. Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia.
Li C; Tian Y; Wang J; Zhu L; Huang L; Wang N; Xu D; Cao Y; Li J; Zhou J
Transl Res; 2014 Jun; 163(6):565-77. PubMed ID: 24524877
[TBL] [Abstract][Full Text] [Related]
5. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic features of aggressive natural killer cell leukemia].
Liu EB; Chen HS; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):810-4. PubMed ID: 22336205
[TBL] [Abstract][Full Text] [Related]
8. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
9. Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia.
El Hussein S; Patel KP; Fang H; Thakral B; Loghavi S; Kanagal-Shamanna R; Konoplev S; Jabbour EJ; Medeiros LJ; Khoury JD
Am J Surg Pathol; 2020 Sep; 44(9):1235-1243. PubMed ID: 32590457
[TBL] [Abstract][Full Text] [Related]
10. [Aggressive NK-cell leukemia: report of nine cases and review of literature].
Sino-US Shanghai Leukemia Cooperative Group
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):116-9. PubMed ID: 16732967
[TBL] [Abstract][Full Text] [Related]
11. Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature.
Ryder J; Wang X; Bao L; Gross SA; Hua F; Irons RD
Int J Hematol; 2007 Jan; 85(1):18-25. PubMed ID: 17261497
[TBL] [Abstract][Full Text] [Related]
12. Aggressive natural killer cell leukemia presenting with hemophagocytic lymphohistiocytosis.
Petterson TE; Bosco AA; Cohn RJ
Pediatr Blood Cancer; 2008 Mar; 50(3):654-7. PubMed ID: 17853464
[TBL] [Abstract][Full Text] [Related]
13. Adult aggressive natural killer cell leukemia.
Zhang H; Meng Q; Yin W; Xu L; Lie L
Am J Med Sci; 2013 Jul; 346(1):56-63. PubMed ID: 23241562
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and Pathological Characteristics of Aggressive Natural Killer Cell Leukemia Patients].
Wang LP; Yu YP; Mei JG; Song P; An ZM; Zhou XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1093-1100. PubMed ID: 34362487
[TBL] [Abstract][Full Text] [Related]
15. Significance of chemokine receptor expression in aggressive NK cell leukemia.
Makishima H; Ito T; Asano N; Nakazawa H; Shimodaira S; Kamijo Y; Nakazawa Y; Suzuki T; Kobayashi H; Kiyosawa K; Ishida F
Leukemia; 2005 Jul; 19(7):1169-74. PubMed ID: 15902300
[TBL] [Abstract][Full Text] [Related]
16. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
18. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
Nicolae A; Ganapathi KA; Pham TH; Xi L; Torres-Cabala CA; Nanaji NM; Zha HD; Fan Z; Irwin S; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2017 Jan; 41(1):67-74. PubMed ID: 27631517
[TBL] [Abstract][Full Text] [Related]
19. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
Park JA; Jun KR; Nam SH; Ghim TT
Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
